<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813083</url>
  </required_header>
  <id_info>
    <org_study_id>20494</org_study_id>
    <nct_id>NCT02813083</nct_id>
  </id_info>
  <brief_title>Detection of Pathological Lymphocytes in Patients With Autoimmune Disease</brief_title>
  <official_title>Detection of Pathological Lymphocytes in Patients With Autoimmune Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will help the investigators design a method to detect the disease-causing immune&#xD;
      cells in patients with rheumatoid arthritis (RA). Such methods are not currently available,&#xD;
      but if successful, would help scientists to better understand the causes of RA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are interested in learning about the immune cells in the blood that&#xD;
      contribute to disease in patients with rheumatoid arthritis (RA). They have developed a&#xD;
      method for identifying a specific type of immune cells that can react against normal tissues&#xD;
      in the body.&#xD;
&#xD;
      In this study, the investigators will enroll RA patients from the University of Minnesota&#xD;
      clinics, collect blood samples from enrolled patients, and process the blood samples to&#xD;
      isolate DNA, RNA, serum, and blood cells. They will use the serum to detect whether specific&#xD;
      autoantibodies (Anti-cyclic Citrullinated Peptide, or anti-CCP) are present. In cases where&#xD;
      anti-CCP antibodies are detected, the investigators may quantify the numbers of immune cells&#xD;
      present that contain receptors with the same anti-CCP specificity. They may also test whether&#xD;
      the numbers of immune cells with these receptors correlate with measures of disease activity&#xD;
      in RA patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>DAS28-ESR</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">155</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <arm_group>
    <arm_group_label>Rheumatoid Arthritis</arm_group_label>
    <description>Rheumatoid arthritis patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention (observational)</intervention_name>
    <description>No intervention (observational)</description>
    <arm_group_label>Rheumatoid Arthritis</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, peripheral blood mononuclear cells&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators will enroll 155 rheumatoid arthritis patients from the University of&#xD;
        Minnesota Rheumatology clinics.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of rheumatoid arthritis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of rituximab immediately prior to visit&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Mueller, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota Department of Medicine</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 22, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

